Company: JUNS
Filing Date: 2025-03-28
Form Type: 10-K
Source: 0001641172-25-001261
Chunk: 259

Company: JUPITER NEUROSCIENCES, INC.
Filing Date: 2025-03-28
Form: 10-K
Item: Item 9C
Chunk 259
---
 of these financial statements

F-4

JUPITER
NEUROSCIENCES, INC.

STATEMENTS
OF CHANGES IN STOCKHOLDERS’ EQUITY (DEFICIT)

    Shares  
    Amount  
    in
    Capital  
    Deficit  
    Deficit 

    Common
    Stock  
    Additional
    Paid  
    Accumulated  
    Total Stockholders’
                                                                                Equity 

    Shares  
    Amount  
    in
    Capital  
    Deficit  
     (Deficit) 
  
    December
    31, 2023 
     26,526,405  
    $2,652  
    $17,778,498  
    $(23,582,504) 
    $(5,801,354)
  
    Stock-based
    compensation 
     -  
     -  
     1,840,908  
     -  
     1,840,908 
  
    Issuance
    of restricted stock units for forgiveness of accrued salary 
     -  
     -  
     10,000  
     -  
     10,000 
  
    Issuance
    of stock options for forgiveness of accrued salary 
     -  
     -  
     50,000  
     -  
     50,000 
  
    Restricted
    stock issued for consulting agreements 
     3,487,500  
     349  
     (349) 
     -  
     - 
  
    Sale
    of common stock 
     112,500  
     11  
     149,989  
     -  
     150,000 
  
    Stock
    issued in connection with automatic conversion of convertible notes 
     227,447  
     23  
     636,843  
     -  
     636,866 
  
    Stock
    sold in offering, net of offering costs 
     2,750,000  
     275  
     9,724,938  
     -  
     9,725,213 
  
    Reconciling
    shares due to forward stock split 
     8  
     -  
     -  
     -